Results 301 to 310 of about 121,985 (386)

An overview of the non‐procedural treatment options for peripheral neuropathic pain

Muscle &Nerve, Volume 71, Issue 5, Page 791-801, May 2025.
Abstract Peripheral neuropathic pain is common in patients with peripheral nerve injury and can significantly impact both their function and quality of life. There is a wide variety of non‐interventional treatment approaches, including pharmacologic therapy, physical/occupational therapy, modalities (therapeutic, mechanical, thermal, etc.), psychology,
Evan R. Zeldin, Adam R. Goddard, Maxwell S. Boyle, Renee L. Madathil, Erick Rosenvall, Kajri A. Majithia, Eric J. Morrison   +6 more
wiley   +1 more source

Unveiling Prescribing Patterns: A Systematic Review of Chronic Opioid Prescriptions After Head and Neck Cancer Surgeries

Otolaryngology–Head and Neck Surgery, Volume 172, Issue 5, Page 1512-1520, May 2025.
Abstract Objective This study aims to review opioid prescribing changes for pain management in head and neck cancer (HNC) surgery patients, given the recent focus on Enhanced Recovery After Surgery protocols. Data Sources MEDLINE, Embase, and CENTRAL, covering 1998 to 2023.
Sabin Karki, Brooke Stephanian, Mirian Ramirez, Michael G. Moore, David A. Campbell, Diane W. Chen, Michael W. Sim, Jessica A. Yesensky, Avinash Mantravadi, Janice L. Farlow   +9 more
wiley   +1 more source

Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 5, May 2025.
ABSTRACT Purpose Tamoxifen is guideline treatment for premenopausal women with estrogen receptor‐positive (ER+) breast cancer. Therapeutic efficacy relies partly on tamoxifen biotransformation by CYP2D6, CYP2C19, and CYP3A4 enzymes. We conducted a cohort study to evaluate whether concomitant prescription of drugs that inhibit these enzymes impacted ...
Kirsten M. Woolpert, Deirdre P. Cronin‐Fenton, Per Damkier, Anders Kjærsgaard, Stephen Hamilton‐Dutoit, Bent Ejlertsen, Richard F. MacLehose, Peer Christiansen, Rebecca A. Silliman, Timothy L. Lash, Thomas P. Ahern, Lindsay J. Collin   +11 more
wiley   +1 more source

Buprenorphine's Effect on the Human Immune System and Inflammation. [PDF]

Clin Transl Sci
Shin SD, Branning R, McGinnis M, Shin A, Ho MF, Karpyak VM, Oesterle T.   +6 more
europepmc   +1 more source

Exploring the role of urine drug screening in opioid agonist therapy

Medical Journal of Australia, Volume 222, Issue 8, Page 381-383, May 2025.
Grace FitzGerald, Sione Crawford, Adrian J Dunlop, Jon Cook, Dean Membrey, Paul MacCartney, Thileepan Naren   +6 more
wiley   +1 more source

Application of NanoScope in Treating Severe Shoulder Dysplasia With Intraarticular Osseous Bodies in a Cat

Veterinary Medicine and Science, Volume 11, Issue 3, May 2025.
Relevance and novel information: This is the first report to describe diagnostic needle arthroscopy in the shoulder joint in a cat. Needle arthroscopy achieved acceptable diagnostic results and should be considered as an alternative arthroscopic technique for smaller joints.
Julian Hauer, Barbara Bockstahler, Carina Strohmayer, Sabine Breit, Barbara Richter, Eva Schnabl‐Feichter   +5 more
wiley   +1 more source

Intrathecal drug delivery systems: A case series advancing surgical, clinical, and technological safety with broader implications for invasive neuromodulation therapies. [PDF]

SAGE Open Med Case Rep
Mo B, Sacks S, Markar J.
europepmc   +1 more source

Successful Treatment With Intravenous Lipid Emulsion of Accidental Amantadine Overdose: A Case Report

Veterinary Medicine and Science, Volume 11, Issue 3, May 2025.
Intravenous lipid emulsion therapy may be an appropriate treatment for amantadine toxicity. While amantadine levels were not performed, clinical signs improved following intravenous lipid emulsions. Additional studies recommend evaluating direct changes to amantadine levels with this therapy in the future.
Brett Hogberg, Kristen Marshall, Mark Vardanega   +2 more
wiley   +1 more source

Optimal Drug, Optimal Dose, or Both in the Pharmacological Treatment of Neonatal Opioid Withdrawal Syndrome?

Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1182-1184, May 2025.
Walter K. Kraft
wiley   +1 more source

Abuse of gabapentinoids in individuals with substance use disorders

Journal of Forensic Sciences, Volume 70, Issue 3, Page 1125-1132, May 2025.
Abstract The abuse of gabapentinoids has increased rapidly, and death cases have been reported with increasing rates. This study examines the toxicological analysis data of substance abuse cases conducted after legal regulations were implemented in Türkiye.
İnci Sağlam, Rukiye Aslan, Serap Annette Akgür, Yusuf Kurtulmuş   +3 more
wiley   +1 more source